Gene-Editing Stocks Dive As Creator Of CRISPR Babies Goes To PrisonInvestors Business Daily • 12/30/19
This CRISPR Stock Is A 2020 Top Pick — But Will Gene Editing Succeed?Investors Business Daily • 12/20/19
Find Strong Stocks Heading into 2020 with this First Profit ScreenZacks Investment Research • 12/10/19
CRISPR Therapeutics: Progress In Treatment Of Blood Disorders Using CRISPR/Cas9 Looks Highly PromisingSeeking Alpha • 12/02/19
Crispr's Gene-Editing Therapy Found Effective In Treating Blood Disorders In Early-Stage StudyBenzinga • 11/19/19